Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle.

[1]  N. Haas,et al.  Dose-dependent effects of combined IGF-I and TGF-β1 application in a sheep cervical spine fusion model , 2003, European Spine Journal.

[2]  N. Ashammakhi,et al.  Spotlight on naturally absorbable osteofixation devices. , 2003, The Journal of craniofacial surgery.

[3]  Britt Wildemann,et al.  Synergistic effect of IGF-I and TGF-ß1 on fracture healing in ratsSingle versus combined application of IGF-I and TGF-ß1 , 2003 .

[4]  Hai-sheng Li,et al.  Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devicesAn experimental study on spinal fusion in pigs , 2003, Acta orthopaedica Scandinavica.

[5]  Thomas Mittlmeier,et al.  Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors. , 2002, Journal of neurosurgery.

[6]  K. Kusumoto,et al.  Osteoinduction by Recombinant Human Bone Morphogenetic Protein-2 in Muscles of Non-Human Primates , 2002, The Journal of international medical research.

[7]  N P Haas,et al.  Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. , 2002, Bone.

[8]  H. Seeherman,et al.  Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model , 2001, The Journal of bone and joint surgery. American volume.

[9]  T. Sugiyama,et al.  An immuno-light- and electron-microscopic study of the expression of bone morphogenetic protein-2 during the process of ectopic bone formation in the rat. , 2001, Archives of oral biology.

[10]  N P Haas,et al.  Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. , 2001, Bone.

[11]  P. Boyne,et al.  Application of Bone Morphogenetic Proteins in the Treatment of Clinical Oral and Maxillofacial Osseous Defects , 2001, The Journal of bone and joint surgery. American volume.

[12]  M. Magin,et al.  Improved Lumbar Vertebral Interbody Fusion Using rhOP-1: A Comparison of Autogenous Bone Graft, Bovine Hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in Sheep , 2001, Spine.

[13]  K. Kusumoto,et al.  Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. , 2000, International journal of oral and maxillofacial surgery.

[14]  H. Uludaǧ,et al.  Carrier systems for bone morphogenetic proteins. , 1999, Clinical orthopaedics and related research.

[15]  A. Mikos,et al.  Synthetic biodegradable polymers for orthopaedic applications. , 1999, Clinical orthopaedics and related research.

[16]  Andreas Lendlein,et al.  Polymere als Implantatwerkstoffe , 1999 .

[17]  William A. Pierce,et al.  Effect of Recombinant Human Bone Morphogenetic Protein‐2 on Fracture Healing in a Goat Tibial Fracture Model , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  Y. Jin,et al.  Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor beta. , 1998, International journal of oral and maxillofacial surgery.

[19]  K. Kusumoto,et al.  Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. , 1998, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[20]  T. Gerhart,et al.  Healing Bone Using Recombinant Human Bone Morphogenetic Protein 2 and Copolymer , 1998, Clinical orthopaedics and related research.

[21]  I. Ishikawa,et al.  Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2). , 1997, Journal of medical and dental sciences.

[22]  M. Hürzeler,et al.  Guided bone regeneration around dental implants in the atrophic alveolar ridge using a bioresorbable barrier. An experimental study in the monkey. , 1997, Clinical oral implants research.

[23]  P. Aspenberg,et al.  BMP-2 for intramuscular bone induction: effect in squirrel monkeys is dependent on implantation site. , 1996, Acta orthopaedica Scandinavica.

[24]  K. Kusumoto,et al.  Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. , 1995, Biochemical and biophysical research communications.

[25]  J. Mordenti,et al.  Pharmacokinetics and Tissue Distribution of Recombinant Human Transforming Growth Factor Beta1 After Topical and Intravenous Administration in Male Rats , 1994, Pharmaceutical Research.

[26]  P. Leung,et al.  Absorbable intramedullary implants for hand fractures. Animal experiments and clinical trial. , 1992, The Journal of bone and joint surgery. British volume.

[27]  K. Takaoka,et al.  Telopeptide‐depleted bovine skin collagen as a carrier for bone morphogenetic protein , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  T. Lindholm,et al.  Bovine bone morphogenetic protein (bBMP/NCP)-induced repair of skull trephine defects in pigs. , 1988, Clinical orthopaedics and related research.

[29]  J O Hollinger,et al.  Biodegradable bone repair materials. Synthetic polymers and ceramics. , 1986, Clinical orthopaedics and related research.

[30]  E. Froesch,et al.  Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. , 1986, The Journal of clinical investigation.

[31]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[32]  N. Haas,et al.  Insulin-like growth factor-1 and transforming growth factor-beta1 accelerates osteotomy healing using polylactide-coated implants as a delivery system: a biomechanical and histological study in minipigs. , 2002, Bone.

[33]  N P Haas,et al.  Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. , 2001, Journal of biomedical materials research.

[34]  U. Ripamonti,et al.  Transforming growth factor-beta 1: induction of bone morphogenetic protein genes expression during endochondral bone formation in the baboon, and synergistic interaction with osteogenic protein-1 (BMP-7). , 1998, Growth factors.

[35]  Y. Ikada,et al.  Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein. , 1998, Journal of biomaterials science. Polymer edition.

[36]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[37]  P. Leung,et al.  ABSORBABLE INTRAMEDULLARY IMPLANTS FOR HAND FRACTURES , 1992 .